These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1143692)

  • 1. [Therapeutic action of S-adenosylmethionine in some chronic hepatopathies].
    Labò G; Gasbarrini GB
    Minerva Med; 1975 May; 66(33):1563-70. PubMed ID: 1143692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [S-Adenosylmethionine: plasma levels in hepatic cirrhosis and preliminary results of its clinical use in hepatology. Double-blind study].
    Ideo G
    Minerva Med; 1975 May; 66(33):1571-80. PubMed ID: 1095962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relations between protidopoiesis and biological transmethylations: action of S-adenosylmethionine on protein crasis in chronic hepatopathies].
    Cantoni L; Maggi G; Mononi G; Preti G
    Minerva Med; 1975 May; 66(33):1581-9. PubMed ID: 1095963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Double-blind studies of the therapeutic action of S-Adenosylmethionine (SAMe) in oral administration, in liver cirrhosis and other chronic hepatitides].
    Miglio F; Stefanini GF; Corazza GR; D'Ambro A; Gasbarrini G
    Minerva Med; 1975 May; 66(33):1595-9. PubMed ID: 1095965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of S-adenosylmethionine (SAM) in the treatment of chronic liver diseases].
    Silvi G; Rina D; Giannelli G
    Clin Ter; 1980 Feb; 92(3):241-50. PubMed ID: 7449310
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double-blind polycentric study of the action of S-adenosylmethionine in hepatic cirrhosis].
    Labo G; Miglio F; D'Ambro A; Bellobuono A; Ideo G; Dioguardi N; Bernardi M; Corazza GR; Gasbarrini G; Avogaro P; Pasquino M
    Minerva Med; 1975 May; 66(33):1590-4. PubMed ID: 1095964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical trial of coenzyme A in hepatopathies].
    Magaraci G
    Minerva Med; 1976 Feb; 67(8):512-8. PubMed ID: 943732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behaviour of ammonemia during treatment of chronic/hyperammonemic hepatopathy with S-adenosyl-L-methionine].
    De Caprio M; Carbone G; Cerotto GM; Corbosiero L; Vitale A
    Clin Ter; 1980 Mar; 92(6):587-602. PubMed ID: 7460488
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antisteatosic activity of 2-MPG (Thiola). Study with the (BSF) dynamic test and with liver biopsy before and after the treatment].
    Surrenti C; Arcangeli A; Casini A
    Minerva Med; 1978 Dec; 69(61):4251-6. PubMed ID: 733081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ; Borg R
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract]   [Full Text] [Related]  

  • 13. [A trial of using Geptral in patients with chronic liver diseases].
    Gorbakov VV; Kalinin AV; Ermolin SN
    Voen Med Zh; 1996 Dec; 317(12):29-31. PubMed ID: 9163214
    [No Abstract]   [Full Text] [Related]  

  • 14. [New trends in the therapy of chronic liver diseases. Significance of Sam-dependent transmethylations].
    Garassini G; Sarnari V
    Minerva Gastroenterol; 1974; 20(1):19-26. PubMed ID: 4827982
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 16. [S-adenosylmethionine as a regulator of protein synthesis. Influence on plasmatic fibrinogen].
    Frezza M; Pozzato G; Valente G; Gilotta S; Milani S; Nicolini R
    Minerva Med; 1977 Apr; 68(17):1105-14. PubMed ID: 857203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Various effects of SAM dependent transmethylations in hepatology].
    Labò G; Gasbarrini G; Miglio F
    Minerva Med; 1972 May; 63(35):2007-17. PubMed ID: 5029206
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 19. [Parenteral S-adenosylmethionine compared to placebos in the treatment of alcoholic liver diseases].
    Diaz Belmont A; Dominguez Henkel R; Uribe Ancira F
    An Med Interna; 1996 Jan; 13(1):9-15. PubMed ID: 8679834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term therapy of liver diseases].
    Markoff N
    Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.